Importantly, injectable therapies such as WEGOVY and ZEPBOUND are unlikely to lose relevance
Accessed 18th March, 2026
doi: 10.1016/S0149-2918(04)90181-6 42 Jiawei HanKM
In China, beyond the in-market products such as semaglutide and tirzepatide and promising global pipeline assets including orforglipron (oral), MariTide (monthly injectable) and retatrutide (triple agonist), a range of China-only molecules is also emerging with strong competitiveness (see Table 2)
Impact of dietary incorporation of spirulina ( Arthrospira platensis ) and exogenous enzymes on broiler performance, carcass traits, and meat quality
Supports Biosynthesis Of Acetylcholine, A Key Neurotransmitter For Brain And Nerve Function